Details for New Drug Application (NDA): 201087
✉ Email this page to a colleague
The generic ingredient in AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE is amlodipine besylate; hydrochlorothiazide; valsartan. There are fifty drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amlodipine besylate; hydrochlorothiazide; valsartan profile page.
Summary for 201087
| Tradename: | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE |
| Applicant: | Strides Pharma Intl |
| Ingredient: | amlodipine besylate; hydrochlorothiazide; valsartan |
| Patents: | 0 |
Pharmacology for NDA: 201087
| Mechanism of Action | Angiotensin 2 Receptor Antagonists Calcium Channel Antagonists Cytochrome P450 3A Inhibitors |
| Physiological Effect | Increased Diuresis |
Suppliers and Packaging for NDA: 201087
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | amlodipine besylate; hydrochlorothiazide; valsartan | TABLET;ORAL | 201087 | ANDA | Golden State Medical Supply, Inc. | 51407-668 | 51407-668-30 | 30 TABLET, FILM COATED in 1 BOTTLE (51407-668-30) |
| AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | amlodipine besylate; hydrochlorothiazide; valsartan | TABLET;ORAL | 201087 | ANDA | Golden State Medical Supply, Inc. | 51407-669 | 51407-669-30 | 30 TABLET, FILM COATED in 1 BOTTLE (51407-669-30) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE;12.5MG;160MG | ||||
| Approval Date: | Jun 1, 2015 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE;25MG;160MG | ||||
| Approval Date: | Jun 1, 2015 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE;12.5MG;160MG | ||||
| Approval Date: | Jun 1, 2015 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
